#GivingNewsDay Donate before midnight and get a thank-you gift!
DONATE
Skip to content
ProPublica Donate
ProPublica Donate

Qualtex Laboratories

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Blood Supply Related (NTEE)

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$127M (2022)

Expenses
$119M (2022)

Total Assets
$83.8M (2022)

Total Liabilities
$24.7M (2022)

Source: Form 990 tax filings from 2011 to 2022

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$127,110,342
Expenses
$119,273,306
Net Income
$7,837,036
Net Assets
$59,170,126
Notable Sources of Revenue Percent of Total Revenue
Contributions $439,561
0.3%
Program Services $124,295,943
97.8%
Investment Income $912
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $2,373,926
1.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $370,656
0.3%
Professional Fundraising Fees $0
Other Salaries and Wages $9,808,920
8.2%
Assets/Debt
Total Assets $83,822,767
Total Liabilities $24,652,641
Net Assets $59,170,126
Compensation
Key Employees and Officers Compensation Related Other
Mark Edward Fite (Coo) $352,904 $0 $18,750
Jose Raul Garcia (Vice President, Sales) $222,283 $0 $33,792
Michael Alan Lindenbaum (Manager Inside Sales) $205,176 $0 $30,411
Delia Teresa Sanchez Watkins (Director, Laboratory Services) $172,536 $0 $13,710
Chesinta Voma (Director Clinical Laboratory) $165,763 $0 $37,186
Promise Rene Trevino (Corporate Account Executive) $159,153 $0 $26,761
Amy Sue Ryall (Director, Customer Ops) $149,260 $0 $17,181
Biobridge Global (Sole Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$123,906,915
Expenses
$122,688,808
Net Income
$1,218,107
Net Assets
$51,929,849
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $121,194,269
97.8%
Investment Income $437,931
0.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $2,274,715
1.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $346,652
0.3%
Professional Fundraising Fees $0
Other Salaries and Wages $11,236,330
9.2%
Assets/Debt
Total Assets $74,789,123
Total Liabilities $22,859,274
Net Assets $51,929,849
Compensation
Key Employees and Officers Compensation Related Other
Michael Alan Lindenbaum (Manager Inside Sales) $205,176 $0 $29,878
Jose Raul Garcia (Vice President, Sales) $203,959 $0 $31,056
Edward Carter Iii (Coo (Thru 06/2021)) $177,863 $154,203 $21,455
Chesinta Voma (Director Clinical Laboratory) $148,908 $0 $28,941
Delia Teresa Sanchez Watkins (Director, Laboratory Services) $141,305 $0 $11,396
Promise Rene Trevino (Corporate Account Executive) $139,215 $0 $26,211
Mark Edward Fite (Coo (Start 06/2021)) $134,020 $125,417 $30,585
Biobridge Global (Sole Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$107,676,474
Expenses
$109,968,479
Net Income
-$2,292,005
Net Assets
$50,318,024
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $103,896,963
96.5%
Investment Income $526,932
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $115,862
0.1%
Net Inventory Sales $0
Other Revenue $3,136,717
2.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $538,812
0.5%
Professional Fundraising Fees $0
Other Salaries and Wages $11,204,605
10.2%
Assets/Debt
Total Assets $82,146,014
Total Liabilities $31,827,990
Net Assets $50,318,024
Compensation
Key Employees and Officers Compensation Related Other
Edward Carter Iii (Coo) $306,884 $0 $19,012
Michael Alan Lindenbaum (Senior Corporate Account Exec.) $202,681 $0 $29,692
Jack Alan Hager Thru 102020 (Vp Laboratory Operations) $200,841 $0 $12,075
Jose Raul Garcia (Vice President, Sales) $189,231 $0 $29,504
Chesinta Voma (Director Clinical Laboratory) $141,074 $0 $32,162
Lorena Aranda Thru 072020 (Director,Immunohematology Refe) $137,547 $0 $10,273
Amy Sue Ryall (Director, Customer Ops & Gencu) $127,857 $0 $15,651
Biobridge Global (Sole Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$140,908,903
Expenses
$138,991,509
Net Income
$1,917,394
Net Assets
$51,213,200
Notable Sources of Revenue Percent of Total Revenue
Contributions $350
0.0%
Program Services $137,600,458
97.7%
Investment Income $679,143
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $2,628,952
1.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $752,132
0.5%
Professional Fundraising Fees $0
Other Salaries and Wages $13,705,679
9.9%
Assets/Debt
Total Assets $88,378,942
Total Liabilities $37,165,742
Net Assets $51,213,200
Compensation
Key Employees and Officers Compensation Related Other
Edward Carter Iii (Coo) $307,716 $0 $18,561
Michael Alan Lindenbau (Senior Corporate Account Exec.) $202,130 $0 $21,670
Steven Andrew Beeler (Vp Operations Ga) $190,263 $0 $25,454
Jose Raul Garcia (Vp Of Sales) $182,425 $0 $31,386
Jack Alan Hager (Vp Laboratory Operations) $177,142 $0 $32,996
Chesinta Voma (Director Clinical Laboratory) $138,349 $0 $31,239
Promise Trevino (Corporate Account Exec.) $127,638 $0 $26,074
Dipakkumar Trikanji Sh (Director Laboratory Services) $127,594 $0 $24,522
Biobridge Global (Sole Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$130,131,643
Expenses
$128,827,119
Net Income
$1,304,524
Net Assets
$47,068,376
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $126,887,632
97.5%
Investment Income $377,033
0.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$20,911
Net Inventory Sales $0
Other Revenue $2,887,889
2.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $717,695
0.6%
Professional Fundraising Fees $0
Other Salaries and Wages $13,282,481
10.3%
Assets/Debt
Total Assets $71,723,215
Total Liabilities $24,654,839
Net Assets $47,068,376
Compensation
Key Employees and Officers Compensation Related Other
Edward Carter Iii (Coo) $303,942 $0 $22,399
Michael Alan Lindenbaum (Senior Corporate Account Exec.) $196,255 $0 $20,492
Steven Andrew Beeler (Vp Operations Ga) $189,642 $0 $25,687
Jose Raul Garcia (Vp Of Sales) $177,571 $0 $29,780
Jack Alan Hager (Vp Laboratory Operations) $171,352 $0 $21,311
Larry Charles Franzoi Jr (Senior Corporate Account Exec.) $163,201 $0 $22,503
Emmanuel Alejandro Casasola (Director Quality Assurance) $129,691 $0 $13,179
Dipak Trikanji Shah (Director Laboratory Services) $122,804 $0 $19,575
Biobridge Global (Sole Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$122,886,469
Expenses
$122,893,881
Net Income
-$7,412
Net Assets
$46,647,097
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $120,703,967
98.2%
Investment Income $549,806
0.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $1,632,696
1.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $518,119
0.4%
Professional Fundraising Fees $0
Other Salaries and Wages $12,720,235
10.4%
Assets/Debt
Total Assets $69,178,656
Total Liabilities $22,531,559
Net Assets $46,647,097
Compensation
Key Employees and Officers Compensation Related Other
Edward Carter Iii (Coo) $280,266 $0 $15,259
Kelli Lynne Riggins (Vp Lab. Services (Thru 07/17)) $207,595 $0 $21,939
Michael Alan Lindenbaum (Senior Corporate Account Exec.) $190,431 $0 $22,330
Larry Charles Franzoi Jr (Senior Corporate Account Exec.) $178,910 $0 $31,054
Steven Andrew Beeler (Vp Operations) $157,203 $0 $19,759
Jose Raul Garcia (Vp Of Sales) $152,171 $0 $35,578
Guy Phillippe Julien (Director Business Integration) $125,419 $0 $20,040
Biobridge Global (Sole Member) $0 $0 $0
Linda Kay Myers (Former Ceo (Thru 12/16)) $0 $603,950 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$111,702,198
Expenses
$114,254,115
Net Income
-$2,551,917
Net Assets
$45,032,578
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $109,246,321
97.8%
Investment Income $468,865
0.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $434,297
0.4%
Net Inventory Sales $0
Other Revenue $1,552,715
1.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $655,614
0.6%
Professional Fundraising Fees $0
Other Salaries and Wages $12,291,877
10.8%
Assets/Debt
Total Assets $58,001,177
Total Liabilities $12,968,599
Net Assets $45,032,578
Compensation
Key Employees and Officers Compensation Related Other
Edward Carter Iii (Coo (Eff. 02/2016)) $279,165 $0 $1,726
Dirk Johnson (Coo (Thru 03/2016)) $190,920 $0 $8,988
Michael Alan Lindenbaum (Corporate Account Executive) $181,557 $0 $21,698
Larry Charles Franzoi Jr (Corporate Account Executive) $173,909 $0 $29,600
Kelli Lynne Riggins (Vp Laboratory Services) $151,989 $0 $33,615
Jose Raul Garcia (Vp Of Marketing & Customer Rel) $134,874 $0 $31,856
Steven Andrew Beeler (Vp Operations) $123,369 $0 $10,108
Thomas Scott Jones (Vp Scientific Affairs) $6,689 $173,150 $32,151
Biobridge Global (Sole Member) $0 $0 $0
Linda Kay Myers (Ceo Bbg (Thru 12/16)) $0 $434,758 $35,943

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$122,296,019
Expenses
$123,143,019
Net Income
-$847,000
Net Assets
$46,923,382
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $119,992,188
98.1%
Investment Income $336,425
0.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $611
0.0%
Net Inventory Sales $0
Other Revenue $1,966,795
1.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $587,997
0.5%
Professional Fundraising Fees $0
Other Salaries and Wages $13,041,330
10.6%
Assets/Debt
Total Assets $63,183,783
Total Liabilities $16,260,401
Net Assets $46,923,382
Compensation
Key Employees and Officers Compensation Related Other
Dirk Johnson (Coo) $360,543 $0 $37,977
Thomas Scott Jones (Vp Scientific Affairs) $216,638 $0 $31,023
Michael Alan Lindenbaum (Corporate Account Executive) $190,510 $0 $21,955
Larry Charles Franzoi Jr (Corporate Account Executive) $182,999 $0 $29,492
Irma G Villarreal (Vp Quality & Compliance) $172,152 $0 $34,396
Kelli Lynne Riggins (Vp Laboratory Services) $167,499 $0 $34,297
Jose R Garcia (Vp Mktg And Customer Relations) $148,260 $0 $31,927
Biobridge Global (Sole Member) $0 $0 $0
Norman D Kalmin (Ceo Emeritus & Med. Dir. Bbg) $0 $146,160 $8,546
Linda Kay Myers (Pres/Coo(thru 02/2014)/Ceo Bbg) $0 $527,901 $33,737

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$145,891,120
Expenses
$132,539,721
Net Income
$13,351,399
Net Assets
$48,423,929
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $144,856,969
99.3%
Investment Income $222
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $1,033,929
0.7%
Notable Expenses Percent of Total Expenses
Executive Compensation $706,462
0.5%
Professional Fundraising Fees $0
Other Salaries and Wages $12,603,848
9.5%
Assets/Debt
Total Assets $66,062,686
Total Liabilities $17,638,757
Net Assets $48,423,929
Compensation
Key Employees and Officers Compensation Related Other
Michael Alan Lindenbaum (Corporate Account Executive) $225,462 $0 $23,408
Dirk Johnson (Coo (Eff. 02/2014)) $221,582 $0 $11,627
Thomas Scott Jones (Vp Scientific Affairs) $200,548 $0 $35,449
Larry Charles Franzoi Jr (Corporate Account Executive) $175,593 $0 $27,114
Irma G Villarreal (Vp Business Integration) $164,286 $0 $30,438
Kelli Lynne Riggins (Vp Laboratory Services) $162,508 $0 $31,151
Jose R Garcia (Vp Mktg & Customer Relations) $155,232 $0 $29,897
Sonya Laverne Gomillion (Cls Technical Specialist) $120,796 $0 $18,222
Biobridge Global (Sole Member) $0 $0 $0
Linda Myers (Pres/Coo(thru 02/2014)/Ceo Bbg) $0 $536,622 $291,152
Norman D Kalmin (Ceo Emeritus & Medical Dir.) $0 $415,528 $45,673

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$125,053,850
Expenses
$115,507,044
Net Income
$9,546,806
Net Assets
$35,256,265
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $122,806,387
98.2%
Investment Income $156
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $2,247,307
1.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,409,805
1.2%
Professional Fundraising Fees $0
Other Salaries and Wages $10,998,856
9.5%
Assets/Debt
Total Assets $53,517,639
Total Liabilities $18,261,374
Net Assets $35,256,265
Compensation
Key Employees and Officers Compensation Related Other
Norman D Kalmin (Ceo Emeritus & Medical Dir.) $413,060 $0 $43,397
Thomas Scott Jones (Vp Scientific Affairs) $190,898 $0 $31,547
Linda Kay Myers (Ceo (Eff 3/2013)/President/Coo) $181,656 $281,452 $31,789
Larry Charles Franzoi Jr (Corporate Acct Executive Ca) $154,063 $0 $5,300
Irma G Villarreal (Vp Business Integration) $153,281 $0 $27,964
Michael Alan Lindenbaum (Corporate Acct Executive Ca) $148,664 $0 $4,425
Jose R Garcia (Vp Mktg & Customer Relations) $145,248 $0 $28,101
Kelli Lynn Riggins (Vp Laboratory Services) $132,944 $0 $21,492
Douglas Armstrong (Director Quality Assurance) $107,031 $0 $6,639
Sonya Laverne Gomillion (Lead Clinical Lab Scientist) $106,462 $0 $15,782
Amy Sue Ryall (Dir. Of Cust. Op. And Mrkting.) $103,845 $0 $12,009
Biobridge Global (Sole Member (Eff 03/2013)) $0 $0 $0
South Texas Blood Tissue Center (Sole Member (Thru 03/2013)) $0 $0 $0
Dennis K Fallen (Ceo (Thru 01/2013)) $0 $159,913 $1,838

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$111,596,430
Expenses
$105,291,348
Net Income
$6,305,082
Net Assets
$25,045,947
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $109,007,486
97.7%
Investment Income $98
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $2,588,846
2.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,431,133
1.4%
Professional Fundraising Fees $0
Other Salaries and Wages $9,806,099
9.3%
Assets/Debt
Total Assets $45,352,295
Total Liabilities $20,306,348
Net Assets $25,045,947

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$100,212,945
Expenses
$95,455,604
Net Income
$4,757,341
Net Assets
$18,804,586
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $98,009,616
97.8%
Investment Income $2,525
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$25,888
Net Inventory Sales $0
Other Revenue $2,226,692
2.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,500,035
1.6%
Professional Fundraising Fees $0
Other Salaries and Wages $9,283,540
9.7%
Assets/Debt
Total Assets $40,215,595
Total Liabilities $21,411,009
Net Assets $18,804,586

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »